Stem cell therapy safety trial for ALS
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests a new treatment made from stem cells (called XS228CN) injected into the spine. It is primarily a safety study, but doctors will also watch for any signs the treatment may slow ALS progression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with definite or probable ALS (not just suspected).
- Your breathing is still fairly strong: your forced vital capacity (FVC, a lung test) is at least 70% of expected for your age and size.
- You are willing to use effective contraception for 6 months after the trial ends (if applicable).
- You do not have other serious health problems like active infections, heart disease, cancer, or liver/kidney issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a single injection given into the spinal fluid (intrathecal) to see if it is safe and might slow down ALS. It uses a specially engineered virus (AAV9) to deliver a treatment directly to the nervous system.
This trial tests a new type of cell therapy called regulatory T cells (Tregs) for people with neurodegenerative diseases like ALS. The goal is to see if these cells can slow down the disease.
This trial tests a new stem cell treatment called NurOwn for people with early-stage ALS. It aims to slow down the disease and improve quality of life.
This study tests an experimental gene therapy called XT-150, which is given as an injection into the fluid around the spinal cord. The goal is to see if it is safe and to gather information that could help treat ALS muscle weakness.
This study tests a new gene therapy called VGN-R13 for people with ALS. It aims to see if the treatment is safe and tolerable, and if it can slow down the disease. You may be able to join if your ALS symptoms started recently and your lung function is still fairly good.
This trial tests whether a transplant of special cells from donated umbilical cord blood can help slow or improve symptoms of ALS (amyotrophic lateral sclerosis, also called Lou Gehrig's disease). The cells may help repair nerve damage and reduce disease progression.
Hear when a new Amyotrophic Lateral Sclerosis (ALS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.